Answer to Question 1
D
Feedback:
Alendronate is the only bisphosphonate that has been approved for the treatment of osteoporosis in men. Etidronate is used to treat Paget's disease, postmenopausal osteoporosis, and heterotopic ossification. Pamidronate is used to treat Paget's disease, postmenopausal osteoporosis in women, hypercalcemia of malignancy, and osteolytic bone lesions in cancer patients. Tiludronate is used to treat Paget's disease that is not responsive to other treatment.
Answer to Question 2
D
Feedback:
Weighing the patient is an initial priority because his or her weight will be used to determine appropriate dosing of all medications and will establish a baseline used for evaluation of any potential adverse effects. Other options are all actions the nurse will need to perform, but none are of higher priority than weighing the patient.